AbbVie Inc. (NYSE:ABBV) is included among the 15 Dividend Stocks to Buy for Steady Income. On March 17, Alloy Therapeutics announced an agreement with AbbVie Inc. (NYSE:ABBV) to develop a new antibody ...

On 17 March 2026, Alloy Therapeutics announced a multi-year agreement giving AbbVie access to its ATX-Gx-based antibody ...

Executives at iBio (NASDAQ:IBIO) outlined the scientific and strategic rationale for a myostatin/activin A bispecific antibody program that the company believes could become a next-generation therapy ...

New treatments for neurodegenerative diseases like Alzheimer's, Parkinson's, and motor neuron disease (MND) could be unlocked thanks to microscopic medicines developed by researchers at the University ...

New research suggests the skin does much more than detect damage or keep pathogens out. By tracing how skin cells respond to ...

Astellas Pharma and CytomX Therapeutics first partnered up in March 2020. For $80 million upfront, the Japanese pharma gained access to the biotech’s Probody platform to generate masked antibody ...

“This is a rare opportunity for me personally, this is my only hope to extend my life by any real period at all." The post Man first in Europe to trial new antibody drug for prostate cancer appeared ...

People with MS have persistently high levels of EBV antibodies, a study found, pointing to a way to distinguish MS from ...

Monoclonal antibodies are among the most widely used biologic medicines, with applications ranging from cancer treatment to ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.